Novo Nordisk, a Danish pharmaceutical company, reported about US$19 billion in global sales for Ozempic and US$9 billion for Wegovy in 2024
for example, they may hope to reduce their treatment costs by making their medication last longer, or to minimise their side effects
Reasons for treatment discontinuation include, but are not limited to, gastrointestinal adverse effects, less-than-desired efficacy, high cost, and fear about uncommon or rare adverse effects
Its ability to lower cortisol levels makes it effective in treating these stress-related disorders
Change Your Life Today For Only $249/month Monitoring and Long-Term Management Monitoring and managing a semaglutide-induced rash is crucial for anyone taking this medication